VenoStent is conducting a 200subject, prospective, onetoone randomized controlled trial in dialysis accessHOUSTON, TX / ACCESSWIRE / January 30, 2024 / VenoStent, Inc., a clinicalstage, venturebacked, therapeutic medical device company developing bioabsorbable wraps to improve outcomes for hemodialysis patients, has announced enrollment of its first subjects i... Lire le communiqué |